|
US Patent No.
|
Date of issue
|
Assignee
|
Compound(s)
|
Ref.
|
| US6001996 |
14 Dec, 1999 |
Eli Lilly & Co., Inc. |
Complexes of (carba)cephalosporins with parabens |
52 |
| US7446107 |
4 Nov, 2008 |
TransForm Pharmaceuticals, Inc. |
Itraconazole; cocrystals with acarboxylic acid |
53 |
| US7625910 |
1 Dec, 2009 |
Astra Zeneca AB |
AZD1152; a phosphate prodrug and maleic acid cocrystal |
54 |
| US8097592 |
17 Jan, 2012 |
Astellas Pharma Inc., Kotobuki Pharmaceutical Co. Ltd. |
SGLT-2 Inhibitor, l-proline cocrystal |
55 |
| US8124603 |
28 Feb, 2012 |
Thar Pharmaceutical |
Meloxicam with various carboxylic acids, aliphatic and aromatic, and maltol and ethyl maltol |
56 |
| US8163790 |
24 Apr, 2012 |
New Form Pharmaceuticals, Inc. |
Metronidazole cocrystals with gentisic acid and gallic acid (specific x-ray reflections in each case) and a cocrystal of imipramine HCl and (+)-camphoric acid |
57 |
| US20170044176 A1 |
16 Feb, 2017 |
Euticals Spa |
Cocrystal of tiotropium bromide and lactose monohydrate |
58 |
| US20170224724 A1 |
10 Aug, 2017 |
University Of South Florida |
Co-crystal (ICC) of lithium with salicylic acid and 1-proline |
59 |
| US20170101433 A1 |
13 Apr, 2017 |
Amri Sci. Llc. |
Co-crystal of progesterone and a co-former selected from the group consisting of vanillic acid, benzoic acid, salicylic acid, cinnamic acid, and vanillin. |
60 |
